In a recent study, however, it was found that the number of concomitant KRAS and BRAF mutations increased along with the depth of the wall invasion of sporadic MSS CRC, suggesting that activation of both genes is likely to harbor a synergistic effect and that KRAS could give the tumor an invasive behavior [28]. This evidence concerns the gene KRAS and colorectal carcinoma.